Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06101745 · ClinicalTrials.gov registry record · Phase 2
Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery
A Phase 2 study of Injury of Ureter During Surgery (Disorder), sponsored by Curadel Surgical Innovations.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 336
- Enrollment target
- 10
- Study locations
NCT06101745 is a Phase 2 study of Injury of Ureter During Surgery (Disorder) that is actively recruiting participants, run by Curadel Surgical Innovations. The registered enrollment target is 336 participants. The trial reports 10 study locations across 4 states.
The verdict
NCT06101745, a Phase 2 study of Injury of Ureter During Surgery (Disorder), is actively recruiting participants, sponsored by Curadel Surgical Innovations.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 336 participants
- Enrollment target
- 10
- Study locations
Study Summary
The goal of this clinical trial is to determine if the drug Nizaracianine Triflutate can help surgeons see and avoid the ureters during abdominopelvic surgery. The ureters are thin-wall, collapsible tubes that connect the kidneys to the bladder. They are difficult to see during surgery and are sometimes damaged accidentally. The main questions to answer are: 1) is this drug safe for use in patients undergoing abdominopelvic surgery and 2) can the drug see the ureters while simultaneously providing information about how well they are working. The clinical trial has 3 parts. Surgery patients enrolled in the first part (Phase 2) will receive drug at different doses to determine the best dose. Patients enrolled in the second part (Phase 3A) will be randomly assigned to drug or placebo (sugar), at the best dose from Phase 2, so the two can be compared directly. Patients enrolled in the final part (Phase 3B) will all receive drug at the best dose from Phase 2.
Conditions Studied
Interventions
- DRUG Placebo Comparator
- DRUG Nizaracianine Triflutate
Study Locations (10)
Other
- University Medical Center Groningen - Groningen
- Martini Hospital - Groningen
- Leiden University Medical Centre (LUMC) - Leiden
- Erasmus Medical Centre - Rotterdam
- Isala Zwolle - Zwolle
California
- Cedars Sinai Medical Center - Los Angeles
- Board of Trustees of Leland Stanford Junior University - Redwood City
Florida
- AdventHealth Orlando - Orlando
- AdventHealth Tampa - Tampa
Massachusetts
- University of Massachusetts Chan Medical School - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 336 participants |
| Start Date | 2024-06-28 |
| Est. Completion | 2026-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06101745
The ClinicalTrials.gov registry entry for NCT06101745 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 336 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Curadel Surgical Innovations, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Injury of Ureter During Surgery (Disorder) appearing as the primary indexed condition, and to 2 interventions - of which Placebo Comparator is the first listed.
NCT06101745 reports 10 study locations spanning 4 distinct geographic areas - top geographies include Other, California, Florida.
Frequently Asked Questions
What is clinical trial NCT06101745 about?
NCT06101745 is a clinical study titled "Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery". The goal of this clinical trial is to determine if the drug Nizaracianine Triflutate can help surgeons see and avoid the ureters during abdominopelvic surgery. The ureters are thin-wall, collapsible tubes that connect the kidneys to the bladder. They are difficult to see during surgery and are somet...
What is the current status of trial NCT06101745?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 336 participants. The study started on 2024-06-28. Estimated completion is 2026-08.
What conditions does trial NCT06101745 study?
This clinical trial studies the following conditions: Injury of Ureter During Surgery (Disorder).
What interventions are being tested in trial NCT06101745?
The interventions under investigation include: Placebo Comparator (DRUG), Nizaracianine Triflutate (DRUG).
Who is sponsoring clinical trial NCT06101745?
This trial is sponsored by Curadel Surgical Innovations, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06101745 being conducted?
This trial has 10 study locations across California, Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.